He H, Wang Y, Tang B, Dong Q, Wu C, Sun W
Nat Aging. 2024; 4(4):510-526.
PMID: 38632351
DOI: 10.1038/s43587-024-00609-z.
Ribeiro J, Altinisik N, Rajan N, Verslegers M, Baatout S, Gopalakrishnan J
Front Cell Dev Biol. 2023; 11:1268565.
PMID: 37881689
PMC: 10597653.
DOI: 10.3389/fcell.2023.1268565.
Osman S, Kahraman Cetin N, Erdogdu I, Meteoglu I
Turk J Gastroenterol. 2023; 34(11):1124-1133.
PMID: 37737217
PMC: 10724784.
DOI: 10.5152/tjg.2023.22682.
Alsolami M, Aboalola D, Malibari D, Alghamdi T, Alshekhi W, Jad H
Front Oncol. 2023; 13:1047588.
PMID: 36845691
PMC: 9951231.
DOI: 10.3389/fonc.2023.1047588.
Kristofova M, Ori A, Wang Z
Cells. 2022; 11(2).
PMID: 35053391
PMC: 8774270.
DOI: 10.3390/cells11020275.
miR-27b-3p a Negative Regulator of DSB-DNA Repair.
Peraza-Vega R, Valverde M, Rojas E
Genes (Basel). 2021; 12(9).
PMID: 34573315
PMC: 8471791.
DOI: 10.3390/genes12091333.
ASPM promotes homologous recombination-mediated DNA repair by safeguarding BRCA1 stability.
Xu S, Wu X, Wang P, Cao S, Peng B, Xu X
iScience. 2021; 24(6):102534.
PMID: 34142045
PMC: 8184511.
DOI: 10.1016/j.isci.2021.102534.
Microcephaly family protein MCPH1 stabilizes RAD51 filaments.
Chang H, Lee C, Lu C, Lee W, Yang H, Yeh H
Nucleic Acids Res. 2020; 48(16):9135-9146.
PMID: 32735676
PMC: 7498314.
DOI: 10.1093/nar/gkaa636.
BRIT1 dysfunction confers synergistic inhibition of hepatocellular carcinoma by targeting poly (ADP-ribose) polymerases and PI3K.
Liang Y, Yu L, Zhang D, Zhao X, Gao H, Slagle B
Am J Cancer Res. 2020; 10(6):1900-1918.
PMID: 32642299
PMC: 7339272.
Implication of DNA repair genes in Lynch-like syndrome.
Xicola R, Clark J, Carroll T, Alvikas J, Marwaha P, Regan M
Fam Cancer. 2019; 18(3):331-342.
PMID: 30989425
PMC: 6561810.
DOI: 10.1007/s10689-019-00128-6.
Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly.
Tervasmaki A, Mantere T, Eshraghi L, Laurila N, Tuppurainen H, Ronkainen V
Int J Cancer. 2019; 145(8):2070-2081.
PMID: 30809794
PMC: 6767439.
DOI: 10.1002/ijc.32234.
Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1.
Meyer S, Dunn M, Vidler D, Porter A, Blain P, Jowsey P
FASEB J. 2018; 33(2):2796-2808.
PMID: 30303738
PMC: 6338662.
DOI: 10.1096/fj.201801353R.
Impact of DNA repair and stability defects on cortical development.
Bianchi F, Berto G, Di Cunto F
Cell Mol Life Sci. 2018; 75(21):3963-3976.
PMID: 30116853
PMC: 11105354.
DOI: 10.1007/s00018-018-2900-2.
Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.
Mantere T, Winqvist R, Kauppila S, Grip M, Jukkola-Vuorinen A, Tervasmaki A
PLoS Genet. 2016; 12(1):e1005816.
PMID: 26820313
PMC: 4731077.
DOI: 10.1371/journal.pgen.1005816.
Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.
Liang Y, Gao H, Lin S, Goss J, Du C, Li K
Oncogene. 2014; 34(33):4368-78.
PMID: 25362854
PMC: 4417661.
DOI: 10.1038/onc.2014.367.
Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression.
Alsiary R, Bruning-Richardson A, Bond J, Morrison E, Wilkinson N, Bell S
PLoS One. 2014; 9(5):e97059.
PMID: 24830737
PMC: 4022499.
DOI: 10.1371/journal.pone.0097059.
The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer.
Mai L, Yi F, Gou X, Zhang J, Wang C, Liu G
Mol Cell Biochem. 2014; 392(1-2):95-107.
PMID: 24633962
DOI: 10.1007/s11010-014-2022-6.
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.
Zhang B, Wang E, Dai H, Hu R, Liang Y, Li K
Carcinogenesis. 2013; 34(10):2271-80.
PMID: 23729656
PMC: 3786380.
DOI: 10.1093/carcin/bgt190.
Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1.
Singh N, Basnet H, Wiltshire T, Mohammad D, Thompson J, Heroux A
Proc Natl Acad Sci U S A. 2012; 109(36):14381-6.
PMID: 22908299
PMC: 3437875.
DOI: 10.1073/pnas.1212366109.
A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation.
Salgado J, Aramendia J, Gutierrez C, Gil C, Robles M, Garcia-Foncillas J
Oncol Lett. 2012; 2(5):807-809.
PMID: 22866131
PMC: 3408106.
DOI: 10.3892/ol.2011.328.